Neuropsychiatric symptoms of post-COVID-19 condition in Mexican healthcare personnel.

Authors

DOI:

https://doi.org/10.19136/hs.a23n1.5657

Abstract

Objective: The aim of the present study was to identify anxiety and depression in health personnel who suffered COVID-19, and to associate them with blood inflammatory markers.

Materials and methods: The design of this study was descriptive and cross-sectional. We evaluated 51 healthcare workers who survived COVID-19 disease with Hamilton scales for anxiety and depression, also we calculated inflammatory markers (systemic immune-inflammation index, SII; monocyte lymphocyte ratio, MLR; platelet lymphocyte ratio, PLR; and neutrophil lymphocyte ratio, NLR) using blood venous samples. This study was carried out from August 2021 to December 2022. Statistical analysis was performed using SPSS v. 26.

Results: Our study included 51 healthcare personnel, females (n=29) and males (n=22). The mean age was 40.54 ± 11.00 years. The most frequent acute symptoms for COVID-19 presented were dysgeusia (n=20), anosmia (n=18), and headache (n=17). The most common comorbidities were overweight (n=24), obesity (n=22), and hypertension (n=11). According to the Hamilton Rating Scale for Anxiety (HARS) and Hamilton Rating Scale for Depression Rating (HRSD) we identify anxiety and depression in 72.5% (n=37) and 51% (n=26) within the health personnel, respectively.

Conclusions: In our study, we observed a high frequency of anxiety and depression in healthcare workers with post COVID-19 condition. However, we did not observe an association between inflammatory markers (NLR, PLR, MLR, and SII) with anxiety and depression in health personnel post-COVID-19. We suggest follow-up assessments in healthcare personnel with post-COVID-19 condition, to evaluate if mixed emotional disorders persist.

Keywords: Anxiety; Depression; Mental disorders; Inflammation; COVID-19.

Downloads

Download data is not yet available.

Author Biographies

  • David Ruiz-Ramos, Juárez Autonomous University of Tabasco

    Master in Biomedical Sciences. Academic Division of Health Sciences, Juárez Autonomous University of Tabasco.

     
  • Cecilia Yazmin Alonso-García , Juárez Autonomous University of Tabasco

    Graduated in General Medicine. Academic Division of Health Sciences, Juárez Autonomous University of Tabasco.

     
  • Roberto Esteban Salazar-Rifka, High Specialty Hospital "Centennial of the Mexican Revolution"

    Epidemiology Residency Program. High Specialty Hospital "Centennial of the Mexican Revolution", Morelos, Mexico.

     
  • José Jaime Martínez-Magaña, Yale University School of Medicine

    Doctor in Biomedical Sciences. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

     
  • Germán Alberto Nolasco-Rosales, Juárez Autonomous University of Tabasco

    Master in Biomedical Sciences. Academic Division of Health Sciences, Juárez Autonomous University of Tabasco; Villahermosa, Tabasco, Mexico.

     
  • Mario Villar-Soto, Hospital Regional de Alta Especialidad de Salud Mental

    Medical Specialist in Psychiatry. Mental Health Regional High Specialty Hospital, Villahermosa, Tabasco, Mexico.

     

Downloads

Published

2023-12-16

Issue

Section

Research article

How to Cite

Neuropsychiatric symptoms of post-COVID-19 condition in Mexican healthcare personnel. (2023). Horizonte Sanitario, 23(1), 11-19. https://doi.org/10.19136/hs.a23n1.5657